p16,p53和EGFR表达在头部和部状细胞癌中及其与临床病理学参数的相关性
Shalini Gupta1,2, Pinki Pandey2, Sakshi Verma2
1Department of Pathology, Metropolis Healthcare Pvt. Ltd, New Delhi, India.
Journal of cancer research and therapeutics
|July 18, 2024
概括
评估了p16,人类乳头瘤病毒 (HPV) 的标志物,以及p53和EGFR的瘤抑制剂在头部和部状细胞癌 (HNSCC) 中. 它们的表达与临床因素相关,有助于评估瘤的攻击性.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 口腔状细胞癌 (HNSCC) 是癌症死亡的一个重要原因.
- 人类乳头瘤病毒 (HPV) 16型与HNSCC的病因有关.
- 在状细胞癌中,p16表达作为HPV感染的替代标记.
- p53瘤抑制基因功能障碍和EGFR过度表达与HNSCC进展和预后不佳有关.
研究的目的:
- 为了研究p16,p53和EGFR在HNSCC中的表达.
- 为了将p16,p53和EGFR表达与临床病理学参数相关联.
- 检查p16,p53和EGFR表达之间的关系.
主要方法:
- 一项横截面的观察性研究包括100例HNSCC病例.
- 使用免疫组织化学染色来确定p16,p53和EGFR表达.
- 使用统计分析 (千平方测试) 来评估相关性,P<0.05被认为是显著的.
主要成果:
- 分别在60%,44%和58%的病例中表达了p16,p53和EGFR.
- p16表达与年龄,瘤部位,性习惯和淋巴结参与有显著的关联.
- 与年龄和性习惯相关的p53表达.
- 在p16与p53的免疫组织化学表达和EGFR之间发现了显著的相关性.
结论:
- 免疫组织化学p16表达是HPV的可靠替代标记物.
- 评估p16,p53和EGFR表达为评估HNSCC的攻击性提供了有价值的信息.
- 这些信息可以帮助临床医生为HNSCC患者选择合适的治疗方式.
更多相关视频
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
27.4K
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
8.5K
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
